SCHEMBL6792102

SCHEMBL6792102

COc1cccc(F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656311 1.00
SCHEMBL29461844 0.85
SCHEMBL160602 0.82 BTK (0.47)
SCHEMBL21330640 0.80 MEN1 (0.48)
SCHEMBL6964 0.78
SCHEMBL29427033 0.78
SCHEMBL25097014 0.76 MAPK8 (0.49)
SCHEMBL22758369 0.76 MAPT (0.37)
SCHEMBL31043116 0.76 MAPT (0.37)
SCHEMBL17036733 0.76 TRPV3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114361590-B Electrolyte additive for lithium ion battery, electrolyte and lithium ion battery 松山湖材料实验室 2023-07-25 CN claimed
CN-114805189-A Preparation method of 6-fluoro-3-iodo-2-methoxypyridine 山东百启生物医药有限公司 2022-07-29 CN claimed
CN-114361590-A Lithium ion battery electrolyte additive, electrolyte and lithium ion battery 松山湖材料实验室 2022-04-15 CN claimed
CN-104918939-A Purine inhibitors of human phosphatidylinositol 3-kinase MERCK SHARP & DOHME 2015-09-16 CN claimed
CN-122080069-A Phospholipid compounds and uses thereof 2026-05-26 CN disclosed
WO-2026090104-A1 MODULATORS OF BETA CATENIN AND USES THEREOF DEWPOINT THERAPEUTICS, INC. (US) 2026-04-30 WO disclosed
EP-4709720-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2026-03-18 EP disclosed
US-12479835-B2 Process for preparing 1-([3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide INTERVET INC. (US) 2025-11-25 US disclosed
US-12473314-B2 Phospholipid compounds and uses thereof GILEAD SCIENCES, INC. (US) 2025-11-18 US disclosed
EP-4537828-A2 PHOSPHOLIPID COMPOUNDS AND USES THEREOF Gilead Sciences, Inc. (US) 2025-04-16 EP disclosed
WO-2025040546-A1 PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS PROXYGEN GMBH (AT) 2025-02-27 WO disclosed
EP-4200301-B1 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-02-26 EP disclosed
CN-1196683-C Amino-compound YUNAGA PHARMACEUTICAL CO LTD (JP) 2005-04-13 CN disclosed
US-20040116480-A1 Oxime ether compound and agricultural or horticultural bactericide NIPPON SODA CO., LTD. (JP) 2004-06-17 US disclosed
CN-1136216-C Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component ������ҩ��ʽ���� 2004-01-28 CN disclosed
EP-1362850-A1 OXIME ETHER COMPOUND AND AGRICULTURAL OR HORTICULTURAL BACTERICIDE NIPPON SODA CO., LTD. (JP) 2003-11-19 EP disclosed
CN-1105715-C Novel pyridonecarboxylic acid derivative or salt thereof, and antibacterial agent containing same as active ingredient WAKUNAGA PHARMA CO LTD (JP) 2003-04-16 CN disclosed
CN-1258674-A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component YUNAGA PHARMACEUTICAL CO LTD (JP) 2000-07-05 CN disclosed
CN-1258672-A Amino-compound YUNAGA PHARMACEUTICAL CO LTD (JP) 2000-07-05 CN disclosed
CN-1201459-A Novel pyridonecarboxylic acid derivative or salt thereof, and antibacterial agent containing same as active ingredient WAKUNAGA PHARMA CO LTD (JP) 1998-12-09 CN disclosed